🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

59,53 USD

Máx. histórico

2.925,00

12010 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,96%

Rango 52 semanas

37,06 – 95,49

Variación hoy

-0,07%

Cierre anterior

59,57

Rango de hoy

59,25 – 60,89

Volumen hoy

1.327.132

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,88%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 9 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/04/2025 12,24 12,93 12,23 12,87 +4,29% 5,68% 1.827.700
14/04/2025 12,13 12,46 11,68 12,34 +4,66% 6,43% 1.437.200
11/04/2025 11,02 11,81 10,75 11,79 +6,12% 9,57% 1.755.900
10/04/2025 11,27 11,40 10,37 11,11 -5,85% 9,14% 2.743.400
09/04/2025 9,76 12,47 9,64 11,80 +18,12% 29,05% 4.599.700
08/04/2025 10,80 10,97 9,73 9,99 -2,54% 11,46% 2.268.200
07/04/2025 9,90 11,07 9,57 10,25 -4,03% 15,15% 3.263.400
04/04/2025 11,74 11,96 10,66 10,68 -11,44% 11,12% 2.566.800
03/04/2025 12,13 12,36 11,60 12,06 -4,96% 6,27% 2.402.200
02/04/2025 11,97 12,84 11,89 12,69 +3,97% 7,89% 1.559.200
01/04/2025 12,74 12,92 12,14 12,21 -4,20% 6,12% 1.733.800
31/03/2025 13,40 13,44 12,14 12,74 -7,81% 9,66% 2.848.300
28/03/2025 13,76 13,99 13,66 13,82 +0,14% 2,42% 974.300
27/03/2025 13,99 14,00 13,68 13,80 -0,93% 2,29% 1.437.200
26/03/2025 14,80 14,80 13,74 13,93 -5,43% 7,13% 1.700.300
25/03/2025 15,54 15,54 14,42 14,73 -4,97% 7,21% 1.604.500
24/03/2025 15,00 15,65 14,96 15,50 +4,73% 4,60% 1.193.100
21/03/2025 15,11 15,22 14,69 14,80 -2,05% 3,54% 4.064.700
20/03/2025 15,27 15,72 15,07 15,11 -2,33% 4,26% 1.788.900
19/03/2025 15,02 15,60 14,98 15,47 +2,48% 4,13% 1.266.400
18/03/2025 15,35 15,35 14,82 15,10 -3,24% 3,45% 1.130.500
17/03/2025 15,34 15,86 15,01 15,60 +1,56% 5,57% 831.500
14/03/2025 15,21 15,62 15,13 15,36 +1,92% 3,25% 1.103.700
13/03/2025 15,68 15,78 14,82 15,07 -4,44% 6,12% 1.193.600
12/03/2025 15,07 16,33 14,78 15,77 +4,71% 10,25% 2.362.700
11/03/2025 15,33 15,56 14,23 15,06 -0,99% 8,71% 2.026.400
10/03/2025 16,56 16,87 15,11 15,21 -10,37% 10,66% 2.105.800
07/03/2025 17,58 17,58 16,84 16,97 -3,96% 4,21% 1.355.400
06/03/2025 16,91 17,79 16,83 17,67 +1,84% 5,71% 1.171.700
05/03/2025 17,14 17,41 16,57 17,35 +1,40% 4,90% 1.427.400